Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

被引：0
作者：
Shohei Eto
Yoko Nukui
Miyuki Tsumura
Yu Nakagama
Kenichi Kashimada
Yoko Mizoguchi
Takanori Utsumi
Maki Taniguchi
Fumiaki Sakura
Kosuke Noma
Yusuke Yoshida
Shinichiro Ohshimo
Shintaro Nagashima
Keisuke Okamoto
Akifumi Endo
Kohsuke Imai
Hirokazu Kanegane
Hidenori Ohnishi
Shintaro Hirata
Eiji Sugiyama
Nobuaki Shime
Masanori Ito
Hiroki Ohge
Yasutoshi Kido
Paul Bastard
Jean-Laurent Casanova
Osamu Ohara
Junko Tanaka
Tomohiro Morio
Satoshi Okada
机构：
[1] Hiroshima University Graduate School of Biomedical and Health Science,Department of Pediatrics
[2] Tokyo Medical and Dental University Hospital,Department of Infection Control and Prevention
[3] Kyoto Prefectural University of Medicine,Department of Infection Control and Laboratory Medicine
[4] Osaka City University,Department of Parasitology, Graduate School of Medicine
[5] Tokyo Medical and Dental University,Department of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences
[6] Hiroshima University Hospital,Department of Clinical Immunology and Rheumatology
[7] Hiroshima University Graduate School of Biomedical and Health Science,Department of Emergency and Critical Care Medicine
[8] Hiroshima University Graduate School of Biomedical and Health Sciences,Department of Epidemiology Infectious Disease Control and Prevention
[9] Tokyo Medical and Dental University Hospital,Clinical Research Center
[10] Tokyo Medical and Dental University,Department of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences
[11] Tokyo Medical and Dental University,Department of Child Health and Development
[12] Gifu University Graduate School of Medicine,Department of Pediatrics
[13] Emeritus Professor of Hiroshima University,Department of General Internal Medicine
[14] Hiroshima University Hospital,Department of Infectious Diseases
[15] Hiroshima University Hospital,Laboratory of Human Genetics of Infectious Diseases, Necker Branch
[16] INSERM U1163,St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch
[17] Necker Hospital for Sick Children,Department of Applied Genomics
[18] University of Paris,undefined
[19] Imagine Institute,undefined
[20] The Rockefeller University,undefined
[21] Howard Hughes Medical Institute,undefined
[22] Kazusa DNA Research Institute,undefined
来源：
Journal of Clinical Immunology | 2022年 / 42卷
关键词：
COVID-19; Antibodies to type I IFNs; IFN-α2; IFN-ω; Neutralization assay; IFN-α2 concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1360 / 1370
页数：10
相关论文
共 50 条
  • [21] Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
    Solanich, Xavier
    Rigo-Bonnin, Raul
    Gumucio, Victor-David
    Bastard, Paul
    Rosain, Jeremie
    Philippot, Quentin
    Perez-Fernandez, Xose-Luis
    Fuset-Cabanes, Maria-Paz
    Gordillo-Benitez, Miguel-Angel
    Suarez-Cuartin, Guillermo
    Boza-Hernandez, Enric
    Riera-Mestre, Antoni
    Parra-Martinez, Alba
    Colobran, Roger
    Antoli, Arnau
    Navarro, Sergio
    Rocamora-Blanch, Gemma
    Framil, Mario
    Calatayud, Laura
    Corbella, Xavier
    Casanova, Jean-Laurent
    Morandeira, Francisco
    Sabater-Riera, Joan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (08) : 1733 - 1744
  • [22] Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
    Xavier Solanich
    Raúl Rigo-Bonnin
    Victor-David Gumucio
    Paul Bastard
    Jérémie Rosain
    Quentin Philippot
    Xosé-Luis Perez-Fernandez
    Maria-Paz Fuset-Cabanes
    Miguel-Ángel Gordillo-Benitez
    Guillermo Suarez-Cuartin
    Enric Boza-Hernandez
    Antoni Riera-Mestre
    Alba Parra-Martínez
    Roger Colobran
    Arnau Antolí
    Sergio Navarro
    Gemma Rocamora-Blanch
    Mario Framil
    Laura Calatayud
    Xavier Corbella
    Jean-Laurent Casanova
    Francisco Morandeira
    Joan Sabater-Riera
    Journal of Clinical Immunology, 2021, 41 : 1733 - 1744
  • [23] The majority of severe COVID-19 patients develop anti-cardiac autoantibodies
    Miklós Fagyas
    Béla Nagy
    Arnold Péter Ráduly
    Ivetta Siket Mányiné
    Lilla Mártha
    Gábor Erdősi
    Sándor Sipka
    Enikő Enyedi
    Attila Ádám Szabó
    Zsófia Pólik
    János Kappelmayer
    Zoltán Papp
    Attila Borbély
    Tamás Szabó
    József Balla
    György Balla
    Péter Bai
    Attila Bácsi
    Attila Tóth
    GeroScience, 2022, 44 : 2347 - 2360
  • [24] Type I interferon: From innate response to treatment for COVID-19
    Lin, Fuyu
    Shen, Kunling
    PEDIATRIC INVESTIGATION, 2020, 4 (04) : 275 - 280
  • [25] The majority of severe COVID-19 patients develop anti-cardiac autoantibodies
    Fagyas, Miklos
    Nagy, Bela, Jr.
    Raduly, Arnold Peter
    Manyine, Ivetta Siket
    Martha, Lilla
    Erdosi, Gabor
    Sipka, Sandor, Jr.
    Enyedi, Eniko
    Szabo, Attila Adam
    Polik, Zsofia
    Kappelmayer, Janos
    Papp, Zoltan
    Borbely, Attila
    Szabo, Tamas
    Balla, Jozsef
    Balla, Gyorgy
    Bai, Peter
    Bacsi, Attila
    Toth, Attila
    GEROSCIENCE, 2022, 44 (05) : 2347 - 2360
  • [26] ANTI-INTERFERON ALPHA AUTOANTIBODIES AND THEIR SIGNIFICANCE IN COVID-19
    Petrikov, S. S.
    Borovkova, N., V
    Popugaev, K. A.
    Storozheva, M., V
    Kvasnikov, A. M.
    Godkov, M. A.
    INFEKTSIYA I IMMUNITET, 2022, 12 (02): : 279 - 287
  • [27] Evaluation of Type I Interferon Treatment in Hospitalized COVID-19 Patients: A Retrospective Cohort Study
    Tat, Vivian Y.
    Huang, Pinghan
    Khanipov, Kamil
    Tat, Nathan Y.
    Tseng, Chien-Te Kent
    Golovko, George
    PATHOGENS, 2024, 13 (07):
  • [28] Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
    Ruetsch, Caroline
    Brglez, Vesna
    Cremoni, Marion
    Zorzi, Kevin
    Fernandez, Celine
    Boyer-Suavet, Sonia
    Benzaken, Sylvia
    Demonchy, Elisa
    Risso, Karine
    Courjon, Johan
    Cua, Eric
    Ichai, Carole
    Dellamonica, Jean
    Passeron, Thierry
    Seitz-Polski, Barbara
    FRONTIERS IN MEDICINE, 2021, 7
  • [29] Type I interferon: From innate response to treatment for COVID-19
    Lin Fuyu
    Shen Kunling
    儿科学研究（英文）, 2020, 04 (04) : 275 - 280
  • [30] Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19
    Muskiet, Frits A. J.
    Carrera-Bastos, Pedro
    Pruimboom, Leo
    Lucia, Alejandro
    Furman, David
    NUTRIENTS, 2022, 14 (07)
12345